Medsafe - Latest News [Page 2]

Medsafe requests Ritalin SR be made available

Thursday, 27 September 2007, 2:03 pm | Medsafe

Following Medsafe concerns about the safety profile of the medicine Rubifen SR, Pharmac has announced it will make Ritalin SR available to people who experience serious side-effects following use of Rubifen SR, the subsidised brand of slow-release methylphenidate. More >>

Prexige 200mg and 400mg tablets to be withdrawn

Tuesday, 21 August 2007, 11:25 am | Medsafe

Consents allowing the supply of 200mg and 400mg tablets of the COX-2 anti-inflammatory medicine Prexige have been revoked in New Zealand by the Medicines and Medical Devices Safety Authority, Medsafe. More >>

New use of cancer therapy can halve risk of death

Friday, 10 November 2006, 3:30 pm | Medsafe

MedSafe registration approval has been given for a new use of a cancer treatment for patients diagnosed with indolent non-Hodgkin’s lymphoma (NHL). More >>

Fees increase for the evaluation, approval of meds

Friday, 21 July 2006, 4:19 pm | Medsafe

The Ministry of Health's medicines regulatory arm, Medsafe has announced fees for the evaluation and registration of medicines will go up next month - many for the first time in 15 years or more - because of increased operating costs and changes ... More >>

ReNu MoistureLoc Not Approved For Use In NZ

Wednesday, 12 April 2006, 10:44 am | Medsafe

ReNu MoistureLoc, a Bausch & Lomb product marketed in the United States is not approved for use in New Zealand. More >>

Medsafe Removes Restrictions On Vaxigrip Vaccine

Friday, 6 May 2005, 10:56 am | Medsafe

The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) today removed restrictions on influenza vaccine Vaxigrip. More >>